Fig. 1
Mean levels of tenascin-C in healthy controls and patients with systemic lupus erythematosus with low [Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2 K) <6] and high (SLEDAI-2 K ≥6) disease activity
Fig. 1 | Arthritis Research & Therapy